Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgios Hillas

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Cytokine|April 10, 2012
Levels of angiopoietins 1 and 2 in induced sputum supernatant in patients with COPDVasiliki Bessa, Stelios Loukides, Georgios Hillas, et al.
Cytokine|October 27, 2012
Increased levels of osteopontin in sputum supernatant of smoking asthmaticsGeorgios Hillas, Stelios Loukides, Konstantinos Kostikas, et al.
Pulmonary Pharmacology & Therapeutics|December 28, 2019
Prospective evAluatIon foR inhalation devices in Greek patients with COPD and asthma: The PAIR studyTheodoros Karampitsakos, Georgios Hillas, Eleftherios Zervas, et al.
Respirology (Carlton, Vic.)|May 7, 2011
Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokersGeorgios Hillas, Konstantinos Kostikas, Konstantinos Mantzouranis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2009
Survey and biological insights of pemetrexed-related therapeutic improvement in mesothelioma: The Nancy Centre of Biological Resources' Mesothelioma CohortFotis Vlastos, Georgios Hillas, Philippe Vidal, et al.
Respiratory Medicine|September 29, 2015
Persistent airflow obstruction in patients with asthma: Characteristics of a distinct clinical phenotypeElissavet Konstantellou, Andriana I Papaioannou, Stelios Loukides, et al.
Cytokine|September 3, 2017
The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasisStamatoula Tsikrika, Katerina Dimakou, Andriana I Papaioannou, et al.
COPD|October 10, 2013
Serum angiopoietin-2 and CRP levels during COPD exacerbationsSofia Nikolakopoulou, Georgios Hillas, Despina Perrea, et al.
Advances in Respiratory Medicine|August 25, 2022
Diagnostic Accuracy of Multiple D-Dimer Cutoff Thresholds and Other Clinically Applicable Biomarkers for the Detection and Radiographic Evaluation of Pulmonary EmbolismSerafeim Chrysikos, Ourania Papaioannou, Theodoros Karampitsakos, et al.
Respirology (Carlton, Vic.)|November 4, 2016
Activin A and follistatin in patients with asthma. Does severity make the difference?Anastasia Papaporfyriou, Petros Bakakos, Konstantinos Kostikas, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Cytokine|April 10, 2012
Levels of angiopoietins 1 and 2 in induced sputum supernatant in patients with COPDVasiliki Bessa, Stelios Loukides, Georgios Hillas, et al.
Cytokine|October 27, 2012
Increased levels of osteopontin in sputum supernatant of smoking asthmaticsGeorgios Hillas, Stelios Loukides, Konstantinos Kostikas, et al.
Pulmonary Pharmacology & Therapeutics|December 28, 2019
Prospective evAluatIon foR inhalation devices in Greek patients with COPD and asthma: The PAIR studyTheodoros Karampitsakos, Georgios Hillas, Eleftherios Zervas, et al.
Respirology (Carlton, Vic.)|May 7, 2011
Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokersGeorgios Hillas, Konstantinos Kostikas, Konstantinos Mantzouranis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2009
Survey and biological insights of pemetrexed-related therapeutic improvement in mesothelioma: The Nancy Centre of Biological Resources' Mesothelioma CohortFotis Vlastos, Georgios Hillas, Philippe Vidal, et al.
Respiratory Medicine|September 29, 2015
Persistent airflow obstruction in patients with asthma: Characteristics of a distinct clinical phenotypeElissavet Konstantellou, Andriana I Papaioannou, Stelios Loukides, et al.
Cytokine|September 3, 2017
The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasisStamatoula Tsikrika, Katerina Dimakou, Andriana I Papaioannou, et al.
COPD|October 10, 2013
Serum angiopoietin-2 and CRP levels during COPD exacerbationsSofia Nikolakopoulou, Georgios Hillas, Despina Perrea, et al.
Advances in Respiratory Medicine|August 25, 2022
Diagnostic Accuracy of Multiple D-Dimer Cutoff Thresholds and Other Clinically Applicable Biomarkers for the Detection and Radiographic Evaluation of Pulmonary EmbolismSerafeim Chrysikos, Ourania Papaioannou, Theodoros Karampitsakos, et al.
Respirology (Carlton, Vic.)|November 4, 2016
Activin A and follistatin in patients with asthma. Does severity make the difference?Anastasia Papaporfyriou, Petros Bakakos, Konstantinos Kostikas, et al.
Pageof 8